CXCR2 and prostate cancer: CXCL5 evinces antioxidant properties by upregulating heme oxygenase-1 (HO-1) to counteract H2O2-induced reactive oxygen species (ROS) in a CXCR2-dependent manner in WPMY-1 and prostate cancer cells.